skip to main content
Show Results with:

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment

Horton, Brendan et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

Searching Remote Databases, Please Wait